Keep informed of the latest developments in breast cancer and Pink-Link's latest news. Check back frequently to keep up to date.
If you have news to share and are a Pink-Link Member, Click Here.
If you are not a Pink-Link member, register here to become
a member - it's free!
Breast Cancer Metastasis Increases After Progestin Hormone Therapies
June 6, 2010 by Vicki Tashman, Founder
After menopause,
6 to 10 million women take hormone therapies, which are often a combination of estrogen and progestin, to replace hormones lost from inactive ovaries. Progestin is a hormone that is used to counteract the potentially negative effects of estrogen therapy on the uterus. In studies sponsored by the National Institutes of Health, evidence has been found that estrogen and progestin in hormone therapies increase the risk of breast cancer in post-menopausal women. Now, a
University of
Missouri study has found that progestins can also increase the chance of the cancer metastasizing, or spreading to the lymph nodes.
Broccoli Component Limits Breast Cancer Stem Cells
June 6, 2010 by Vicki Tashman, Founder
A compound derived from broccoli could help prevent or treat breast cancer by targeting cancer stem cells - the small number of cells that fuel a tumor's growth - according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
Breakthrough Method Predicts Risk of DCIS Becoming Invasive Breast Cancer
May 10, 2010 by Vicki Tashman, founder, Pink-Link
For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) - the most common form of non-invasive breast cancer - are at risk of developing more invasive tumors in later years.
May 10, 2010 by Vicki Tashman, Founder of Pink-Link
Tumor cells depend upon estrogens to survive and proliferate in about 70% of all breast cancer cases. The most frequently used treatment to fight this variety of tumors relies on anti-estrogens such as tamoxifen. However, resistance to this type of therapy develops in more than 30% of the patients. Understanding the mechanisms involved in the appearance of resistance to tamoxifen is thus essential to develop new therapeutic approaches.
We are seeking women who have been diagnosed with breast cancer within the past 18 months for a research study. This study is to test an online workbook that teaches skills for coping with breast cancer.
To learn more, visit the study website atwww.cancercoping.org. If you are interested in participating, contact our research coordinator at (206)679-2022, 1-888-825-2742, or via email at study@talariainc.com.
Seventeen years ago, I thought yoga was for "other people", just like I thought cancer was for "other people". That was, before I was first diagnosed with breast cancer at twenty-six. At that time I was far too busy working my way up the corporate ladder, shopping and socializing to recognize the importance of yoga. It wasn't until my third cancer diagnosis at 31 years old, when I lost my hair and my breast, that I started to wonder about my life and my lifestyle.